TRVN logo

Trevena (TRVN) Company Overview

Profile

Full Name:

Trevena, Inc.

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

January 31, 2014

Indexes:

Not included

Description:

Trevena, Inc. is a biopharmaceutical company focused on developing innovative therapies for pain and central nervous system disorders. They create new drugs using their unique technology to improve patient care and outcomes, aiming to address unmet medical needs in the healthcare market.

Key Details

Price

$1.74

Annual Revenue

$3.13 M(+847.61% YoY)

Annual EPS

-$79.00(+58.37% YoY)

Annual ROE

-1014.58%

Beta

1.49

Events Calendar

Earnings

Next earnings date:

Apr 1, 2025

Recent quarterly earnings:

Nov 7, 2024

Recent annual earnings:

Apr 1, 2024
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

N/A
Splits

Next split:

N/A

Recent split:

Aug 13, 2024

Analyst ratings

Recent major analysts updates

Nov 14, 24 HC Wainwright & Co.
Neutral
May 16, 24 HC Wainwright & Co.
Buy
Apr 2, 24 HC Wainwright & Co.
Buy
Mar 11, 24 HC Wainwright & Co.
Buy
May 17, 23 JMP Securities
Market Outperform
Mar 31, 23 JMP Securities
Market Outperform
Mar 31, 23 HC Wainwright & Co.
Buy
May 12, 22 HC Wainwright & Co.
Buy
Mar 15, 21 Oppenheimer
Perform
Sep 14, 20 Guggenheim
Buy

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Market cap

Technical

Dividend

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Profit

EPS

ROA & ROE

EBIT & EBITDA

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PB Ratio

PS Ratio

Enterprise value

EV/EBITDA

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Leverage

Risk & Stability

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Equity

Liabilities

Debt

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Free CashFlow

CAPEX

Institutional Ownership

FAQ

  • What is the ticker symbol for Trevena?
  • Does Trevena pay dividends?
  • What sector is Trevena in?
  • What industry is Trevena in?
  • What country is Trevena based in?
  • When did Trevena go public?
  • Is Trevena in the S&P 500?
  • Is Trevena in the NASDAQ 100?
  • Is Trevena in the Dow Jones?
  • When was Trevena's last earnings report?
  • When does Trevena report earnings?
  • Should I buy Trevena stock now?

What is the ticker symbol for Trevena?

The ticker symbol for Trevena is NASDAQ:TRVN

Does Trevena pay dividends?

No, Trevena does not pay dividends

What sector is Trevena in?

Trevena is in the Healthcare sector

What industry is Trevena in?

Trevena is in the Biotechnology industry

What country is Trevena based in?

Trevena is headquartered in United States

When did Trevena go public?

Trevena's initial public offering (IPO) was on January 31, 2014

Is Trevena in the S&P 500?

No, Trevena is not included in the S&P 500 index

Is Trevena in the NASDAQ 100?

No, Trevena is not included in the NASDAQ 100 index

Is Trevena in the Dow Jones?

No, Trevena is not included in the Dow Jones index

When was Trevena's last earnings report?

Trevena's most recent earnings report was on Nov 7, 2024

When does Trevena report earnings?

The next expected earnings date for Trevena is Apr 1, 2025

Should I buy Trevena stock now?

As of today, analysts generally recommend a 'Hold' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions